Investigating how changes in a specific kidney gene lead to cyst formation
Human-specific Abnormal Alternative Splicing of the Wild-type PKD1 Gene Induces Premature Termination of Polycystin-1
This study is looking into how a gene called PKD1 affects Autosomal Dominant Polycystic Kidney Disease (ADPKD) to help us understand why kidney problems happen and find new ways to treat them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10894639 on NIH RePORTER |
What this research studies
This research focuses on understanding the mechanisms behind Autosomal Dominant Polycystic Kidney Disease (ADPKD), a genetic condition that causes cysts to form in the kidneys. The researchers will explore two main theories about how the disease develops, particularly looking at the role of the PKD1 gene and its protein product, polycystin-1. By using advanced technology to analyze tiny vesicles that carry this protein, they aim to determine how variations in gene expression contribute to kidney dysfunction. This could lead to better insights into disease progression and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Autosomal Dominant Polycystic Kidney Disease.
Not a fit: Patients without a diagnosis of ADPKD or those with other unrelated kidney conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with ADPKD.
How similar studies have performed: Similar research approaches have shown promise in understanding genetic diseases, but this specific investigation into PKD1 and exosome analysis is relatively novel.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Ward, Christopher J — University of Kansas Medical Center
- Study coordinator: Ward, Christopher J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.